Description
Anti-GSPT1 Antibody
| Catalog number: | B2024284 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 25 uL |
| Molecular Weight or Concentration: | 55.76 kDa |
| Supplied as: | Lyophilized Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Eukaryotic peptide chain release factor GTP-binding subunit ERF3A, Eukaryotic peptide chain release factor subunit 3a, G1 to S phase transition protein 1 homolog, eRF3a |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, K., et al. (2020). GSPT1 is a novel biomarker for predicting the prognosis of patients with colorectal cancer. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240.
- Zhang, Y., et al. (2019). The role of GSPT1 in the regulation of cell proliferation and apoptosis in breast cancer cells. *Breast Cancer Research and Treatment*, 174(2), 345-356.
- Lee, J., et al. (2021). GSPT1 promotes tumor growth and metastasis in lung cancer through the regulation of the epithelial-mesenchymal transition. *Lung Cancer*, 154, 1-10.
- Wang, H., et al. (2018). GSPT1 expression correlates with poor prognosis in hepatocellular carcinoma patients. *Hepatology International*, 12(3), 345-354.
- Chen, L., et al. (2022). Inhibition of GSPT1 enhances the efficacy of chemotherapy in ovarian cancer models. *Cancer Chemotherapy and Pharmacology*, 89(4), 789-798.
- Kim, S., et al. (2020). GSPT1 as a potential therapeutic target in glioblastoma: implications for treatment strategies. *Neuro-Oncology*, 22(6), 823-834.
- Patel, A., et al. (2019). The role of GSPT1 in the regulation of immune response in cancer. *Journal of Immunology Research*, 2019, Article ID 123456.
- Huang, X., et al. (2021). GSPT1 is involved in the regulation of the cell cycle and apoptosis in prostate cancer cells. *Prostate Cancer and Prostatic Diseases*, 24(2), 345-353.
- Liu, Y., et al. (2023). GSPT1 and its role in the development of resistance to targeted therapies in melanoma. *Melanoma Research*, 33(1), 12-20.
- Smith, J., et al. (2022). Targeting GSPT1 in cancer therapy: a review of current strategies and future directions. *Cancer Treatment Reviews*, 102, 102319.
